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Abstract
 
The unique tyrosine kinase binding (TKB) domain of Cbl targets phosphorylated tyrosines on
activated protein tyrosine kinases (PTKs); this targeting is considered essential for Cbl proteins
to negatively regulate PTKs. Here, a loss-of-function mutation (G304E) in the c-Cbl TKB do-
main, first identified in 
 
Caenorhabditis elegans
 
, was introduced into a mouse and its effects in
thymocytes and T cells were studied. In marked contrast to the c-Cbl knockout mouse, we
found no evidence of enhanced activity of the ZAP-70 PTK in thymocytes from the TKB do-
main mutant mouse. This finding contradicts the accepted mechanism of c-Cbl–mediated neg-
ative regulation, which requires TKB domain targeting of phosphotyrosine 292 in ZAP-70.
However, the TKB domain mutant mouse does show aspects of enhanced signaling that par-
allel those of the c-Cbl knockout mouse, but these involve the constitutive activation of Rac
and not enhanced PTK activity. Furthermore, the enhanced signaling in CD4
 
 
 
CD8
 
 
 
 double
positive thymocytes appears to be compensated by the selective down-regulation of CD3 on
mature thymocytes and peripheral T cells from both strains of mutant c-Cbl mice.
Key words: CD3 • CD5 • T cell receptor • SH2 domain • Rac
 
Introduction
 
The development of mature T cells in the thymus occurs
via selection processes that are regulated by the affinity of
TCR for MHC–self-peptide complexes and the strength
of downstream signals triggered by this interaction. If
TCR engagement is absent, then immature thymocytes
quickly die of neglect, whereas remaining thymocytes that
receive signals undergo opposing fates of positive or nega-
tive selection. Those receiving strong signals from high
affinity interactions with thymic ligands are actively de-
leted, whereas thymocytes expressing TCRs of lower affin-
ity receive weaker signals that allow survival and differen-
tiation into mature T cells. Therefore, the ability to
generate functional T cells is dependent on precisely con-
trolled mechanisms of ligand engagement and signal trans-
duction. Key questions emerging from this requirement
for precise control are the quantitative and qualitative
identities of the signaling molecules that determine the
strength of the selecting signal.
The strength of the response is initially determined by
the affinity of the TCR for MHC–self-peptide complexes
and the total number of receptor interactions that form af-
ter ligand engagement (for review see references 1, 2). A
protein that has a key role in regulating both TCR num-
bers and the activity of downstream signaling events in thy-
mocytes is c-Cbl (3–5). c-Cbl is a multi-adaptor protoon-
cogene possessing E3 ubiquitin ligase activity by virtue of
its RING finger domain, which recruits ubiquitin-conju-
gating enzymes (E2s) to signaling complexes. The major
class of substrate for c-Cbl–directed polyubiquitylation is
activated protein tyrosine kinases (PTKs).
 
*
 
 Activated PTKs
are recognized by a unique and highly conserved region
common to all Cbl proteins that is comprised of a variant
SH2 domain, a calcium-binding EF hand and a four helix
bundle (6). Because all three domains are required to target
phosphotyrosines in PTKs, this region is collectively
known as a tyrosine kinase binding (TKB) domain.
 
Address correspondence to Wallace Y. Langdon, Dept. of Pathology,
University of Western Australia, 35 Stirling Hwy, Crawley, WA 6009,
Australia. Phone: 61-8-9346-2939; Fax: 61-8-9346-2891; E-mail:
wlangdon@cyllene.uwa.edu.au
 
*
 
Abbreviations used in this paper:
 
 DP, double positive; ES, embryonic stem;
PTK, protein tyrosine kinase; SP, single positive; TKB, tyrosine kinase
binding. T
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Regulation of ZAP-70 in a c-Cbl(G304E) Mouse
 
Analysis of CD4
 
 
 
CD8
 
 
 
 double positive (DP) thy-
mocytes from c-Cbl knockout mice revealed a marked en-
hancement of TCR and CD3 levels (7, 8). This up-regula-
tion appears to be independent of TCR triggering as TCR
transgenic thymocytes maintained in a nonselecting, or
MHC class II–deficient, environment also show elevated
expression of the transgene TCR. This finding led to the
conclusion that c-Cbl is required for antigen-independent
down-regulation of the TCR–CD3 complex on the sur-
face of thymocytes (8). Recent papers on this process in
thymocytes and T cells (9, 10) also support the idea that
c-Cbl functions by promoting degradation (and thereby op-
posing recycling) rather than enhancing ligand-induced in-
ternalization. Thymocytes from c-Cbl
 
 
 
/
 
 
 
 mice also show
marked activation of the ZAP-70 PTK in response to anti-
CD3 stimulation alone (7, 8). This is in contrast to wild-
type thymocytes where ZAP-70 is unresponsive to this sig-
nal in the absence of costimulation of the CD4 receptor.
The crucial role of CD4 cross-linking is to activate the Src
family kinase Lck that phosphorylates ZAP-70 to trigger its
kinase activity. Remarkably, however, in c-Cbl
 
 
 
/
 
 
 
 thy-
mocytes ZAP-70 can be activated without detectable acti-
vation of Lck, suggesting that c-Cbl directly targets ZAP-
70, and not its upstream activators (7). Furthermore, the
enhanced activation of ZAP-70 in c-Cbl
 
 
 
/
 
 
 
 thymocytes
is not solely due to increased TCR and CD3 levels because
the ability of ZAP-70 to phosphorylate its substrates LAT
and SLP-76 is maintained at times when ZAP-70 is down-
regulated in wild-type thymocytes (11). Direct targeting of
ZAP-70 is further implicated by studies showing an inter-
action between the c-Cbl TKB domain and a negative reg-
ulatory tyrosine in ZAP-70 at position 292 (12). These
findings support the proposal by Naramura et al. (8) that
c-Cbl is functioning at two levels: (a) to down-regulate the
surface expression of TCR–CD3 complexes, and (b) to
negatively regulate intracellular signaling by ZAP-70. The
basic premise of this paper (i.e., c-Cbl is a negative regula-
tor of ZAP-70) is based on these studies with c-Cbl
knockout mice.
To better understand the mechanisms of these effects,
we analyzed mice with a loss-of-function mutation in the
c-Cbl TKB domain. This mutation was first identified in
SLI-1, the Cbl orthologue in 
 
Caenorhabditis elegans
 
, as a
glycine to glutamic acid substitution at amino acid 315
(i.e., G315E) that restored vulval induction in worms
with reduction-of-function mutations in the LET-23 re-
ceptor tyrosine kinase (13). These experiments were nota-
ble as they were the first to identify Cbl proteins as nega-
tive regulators of PTKs. Analyses of this mutation in
mammalian cells have revealed that it abolishes both trans-
formation of mouse fibroblasts by oncogenic forms of
c-Cbl and the ability of the TKB domain to interact di-
rectly with activated PTKs (4). A well-studied example of this
is the G306E substitution in the human c-Cbl TKB domain
that abolishes its interaction with the negative regulatory
tyrosine 292 in ZAP-70 (14). The molecular basis for this
is suggested by structural studies showing that G306 lies
near the universally conserved arginine (R294 in human
 
c-Cbl) present in all SH2 domains that hydrogen bonds
with the phosphate group of the incoming tyrosine. A
glutamic acid substitution at 306 could form a buried salt
bridge with R294, thus preventing its interaction with
phosphotyrosine (6).
In this paper, we extend the functional analysis of the
TKB domain by producing mice with a G304E knockin
mutation. The mouse TKB and SH2 domains exhibit
99.4% and 100% identity, respectively, to the human so the
G306E and G304E mutations are identical. Unexpectedly,
we found no evidence of enhanced ZAP-70 activity in the
thymus of this mouse, but we did observe other similarities
to the c-Cbl knockout mouse suggesting that signaling
pathways independent of ZAP-70 are enhanced in both
mutant mice.
 
Materials and Methods
 
Preparation of Targeting Construct.
 
A 15-kb murine c-
 
Cbl
 
 ge-
nomic clone isolated from a 
 
 
 
UNI-ZAP 129 Sv library (7) was
used to construct the G304E targeting vector. A 3.9-kb XbaI
fragment subcloned into pBluescriptSK
 
 
 
 (Stratagene) was
modified by site-directed mutagenesis using the primer
5
 
 
 
TGGGCTATTGAGTATGTTACTGC3
 
 
 
(G304E); the G
 
→
 
A
mutation (underlined) creating a Gly
 
→ 
 
Glu substitution at amino
acid 304. A 3.6-kb SalI-BamHI pGK-neomycin and HSV–thy-
midine kinase cassette flanked by 
 
loxP
 
 sites isolated from the
pFlox vector (provided by P. Orban, EMBL, Heidelberg, Ger-
many) was cloned upstream of the 3.9-kb XbaI G304E frag-
ment. The targeting construct was completed by the addition of
a 1.4-kb fragment upstream of the “floxed” pGKNeo/HSVTK
cassette and a 4.0-kb fragment downstream of the 3.9-kb XbaI
G304E segment, representing c-Cbl genomic sequences imme-
diately 5
 
 
 
 and 3
 
 
 
 of the 3.9–kb XbaI fragment, respectively (see
Fig. 1 A).
The resulting construct was released by restriction enzyme di-
gestion with NotI and XhoI and electroporated into W9.5 129
Sv/J embryonic stem (ES) cells (15). Targeted ES cells were se-
lected in 200 
 
 
 
g/ml G418, individual clones picked and ex-
panded, then genomic DNA isolated and restricted with BamHI
for analysis. ES cell clones that had correctly undergone homolo-
gous recombination were identified first by PCR using prim-
ers external and internal to the targeting construct respectively
(external c-Cbl primer p1, 5
 
 
 
ACGATAGTCCCGTGGAAG-
AGC3
 
 
 
 [T-S204]; and internal 
 
loxP
 
 primer p2, 5
 
 
 
TGC-
TATACGAAGTTATTAGGTCCCTCG3
 
 
 
 [
 
lox
 
P rev]), and then
confirmed by Southern blotting using a 
 
32
 
P-labeled genomic
probe (probe A, 0.8 kb) hybridizing outside the targeting con-
struct (wild-type allele, 5.8 kb; targeted allele, 7.9 kb; see Fig. 1
A). Finally, Southern blotting using a probe to the 
 
Neo
 
 gene was
used to identify clones that had undergone only a single integra-
tion event.
 
Generation of c-Cbl(G304E) Knockin Mice.
 
Two correctly tar-
geted G418-resistant ES cell clones were used to generate chi-
meric mice by microinjection into embryonic C57BL/6J blasto-
cysts. Chimeras (85–100%) were mated with C57BL/6J mice,
and a founder line was established from an agouti pup heterozy-
gous for the G304E mutation. Heterozygous females were
mated with C56BL/6 Cre-
 
deleter
 
 transgenic male mice (16) to
induce in vivo excision of the 
 
loxP
 
-flanked pGKNeo and HSV-
TK cassettes. Successful excision was demonstrated by SouthernT
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blotting of HindIII-digested genomic DNA using a 0.8-kb
probe B (detecting 11.0 vs. 7.2 kb before and after Cre deletion,
respectively; see Fig. 1 A). The resultant “Cre-d” allele retains a
single 34-bp 
 
loxP
 
 site as well as 
 
 
 
70-bp polylinker sequences
incorporated during the construction of the targeting vector,
allowing subsequent genotyping of mice by PCR on tail
DNA  using c-Cbl specific primers p3 (5
 
 
 
TTCTTAGCTCT-
CAATGTTTCTACTCTCC3
 
 
 
; 4.2RI) and p4 (5
 
 
 
CATG-
TAACCAGGGTGAGTTAC3
 
 
 
; VM269R) that flank the 
 
loxP
 
site (PCR product from WT allele 
 
 
 
400 bp, from G304E allele
 
 
 
290 bp; see Fig. 1 A). The presence of the G304E mutation in
the targeted allele(s) was also confirmed by genomic sequencing.
Heterozygous c-Cbl G304E knockin mice from Cre-
 
deleter
 
 mat-
ings were mated together to establish breeding lines from which
all mice used in these experiments were derived.
 
Thymocyte Stimulation and Preparation of Cell Lysates.
 
Thy-
mocytes were stimulated by incubation with biotinylated anti-
CD3 (500A2), anti-CD4 (GK1.5) antibodies, and avidin cross-
linking at 37
 
 
 
C as described previously (11). The cells were
lysed in ice-cold 
 
n
 
-octyl-
 
 
 
-
 
d
 
-glucopyranoside/NP-40 lysis
buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM
EDTA), 1 mM sodium orthovanadate, 0.2% NP-40, 60 mM
 
n
 
-octyl-
 
 
 
-
 
d
 
-glucopyranoside (Sigma-Aldrich), 10 
 
 
 
g/ml apro-
tinin, 1 mM sodium orthovanadate, 10 mM NaF, and 1 
 
 
 
g/ml
each of chymostatin, leupeptin, and pepstatin. After incubating
for 10 min on ice, lysates were cleared by centrifugation at
1,500 
 
g
 
 for 8 min.
 
Immunoprecipitation, Immunoblotting, and Rac GTP Assays.
 
Cleared lysates were analyzed by immunoprecipitation and im-
munoblotting as described previously (11). Anti-Lck and MAPK
antibodies were purchased from Santa Cruz Biotechnology, Inc.,
anti-ZAP-70 and c-Cbl antibodies from Transduction Laborato-
ries, and anti-TCR
 
 
 
 from Zymed Laboratories. Polyclonal rabbit
anti-ZAP-70 and mouse monoclonal antiphosphotyrosine (4G10)
antibodies were provided by L. Samelson (National Institutes of
Health) and B. Druker (Oregon Health and Science University,
Portland, OR), respectively. Antibodies to Akt and phospho-
Akt(Ser473), phospho-p42/44 MAPK(Thr202/Tyr204), SAPK/
JNK, and phospho-SAPK/JNK(Thr183/Tyr185) were purchased
from Cell Signaling Technology. Rac-GTP was precipitated
from thymocytes lysed in 25 mM Hepes, pH 7.4, 150 mM NaCl,
1% NP-40, 10 mM MgCl
 
2
 
, and 10% glycerol by incubation for
30 min at 4
 
 
 
C with agarose-bound GST-PAK-1-PBD (human
PAK-1 amino acid residues 67–150; Upstate Biotechnology) fol-
lowed by three washes with the lysis buffer. Rac1 was detected
by immunoblotting with anti-Rac antibodies (Cat. No. R55620;
Transduction Labs).
 
Flow Cytometry.
 
Single cell suspensions from the thymus,
bone marrow, spleen, and lymph node were stained with anti-
bodies, and 10
 
4
 
 viable cells were analyzed on a Becton Dickin-
son FACSCalibur™ machine. Cells were collected using
CELLQuest software (Becton Dickinson) and further analyzed
using Flo Jo (Tree Star Inc.). The following antibodies were
used: anti–CD3
 
 
 
(145–2C11)-APC and -PE, (17A2)-PE,
(500A2)-PE, anti–TCR
 
 
 
(H57–597)-FITC and -PE, anti–
CD4(RM4–5)-PE, anti–CD8(53–6.7)-FITC, anti–CD5(53–
7.3)-APC, anti–CD11b(M1/70)-PE, anti–Ly-6G(Gr-1)(RB6–
8C5)-FITC, and anti–CD69(H1.2F3)-PE (all from BD
Biosciences). Cells were incubated with anti-CD16/CD32
(2.4G2) before staining to block Fc binding, and dead cells were
gated by propidium iodide staining. To detect intracellular levels
of ZAP-70, c-Cbl, Lck, and TCR
 
 
 
, the cells were fixed and per-
meabilized using a Cytofix/Cytoperm kit (Becton Dickinson)
 
according to the manufacturer’s directions. After incubation
with antibodies to the aforementioned proteins, the cells were
washed extensively in media containing 0.1% saponin. Unla-
beled antibodies were detected with APC-conjugated goat anti–
mouse Ig (BD Biosciences). To detect intracellular levels of
CD3
 
 
 
, the cells were first incubated for two rounds with unla-
beled 145–2C11 before fixing, permeabilizing, and staining with
PE-labeled 145–2C11. To detect intracellular levels of TCR
 
 
 
,
the cells were first incubated for two rounds with FITC-labeled
H57–597 before fixing, permeabilizing, and staining with PE-
labeled H57–597.
 
Results
 
Generation of Mice with a Loss-of-Function Mutation in the
c-Cbl TKB Domain.
 
Mice with a Gly
 
→
 
Glu substitution at
position 304 (i.e., G304E) were generated using 129 Sv/J-
derived ES cells and the targeting construct outlined in Fig.
1 A. To induce deletion of the 
 
lox
 
P-flanked neomycin cas-
sette, heterozygous mice carrying the mutated 
 
c-Cbl
 
 gene
were crossed to the Cre-
 
deleter
 
 strain and the resulting mice
were intercrossed to expand numbers for experimental use.
Genomic DNA was PCR-amplified and sequenced to
confirm the successful introduction of the G304E mutation
(Fig. 1 A). Litters were genotyped by PCR analysis of ge-
nomic DNA extracted from tails at weaning, and the prod-
ucts obtained are shown in Fig. 1 A.
Mice homozygous for G304E c-Cbl (which we term
E/E) were generally healthy, although significantly fewer
than expected homozygous E/E offspring were produced
from 
 
 
 
/E matings (
 
 
 
/
 
 
 
 
 
 
 
 91, 
 
 
 
/E 
 
 
 
 154, and E/E 
 
 
 
31), suggesting that developmental defects are associated
with this mutation.
Examination of organs and tissues revealed no gross ab-
normality except for slight splenomegaly and dilated uter-
ine horns and fallopian tubes in 40% (6/15) of E/E fe-
males examined between the ages of 6–9 wk. The
fallopian tubes and uterine horns showed minimal evi-
dence of tissue hyperplasia, rather the expanded size ap-
peared to be caused by obstruction to the distal genital
tract, resulting in mucous retention. Spleens from the
c-Cbl E/E and 
 
 
 
/
 
 
 
 mice were similar in several respects.
Both were larger compared with normal littermates (E/E 
 
 
 
50% and 
 
 
 
/
 
 
 
 
 
  
 
80%) and were darker in color due to an
expansion of the red pulp (Fig. 1 B, top). In addition, E/E
and c-Cbl
 
 
 
/
 
 
 
 spleens had increased numbers of mega-
karyocytes, megakaryoblasts, and myelocytes, which were
predominantly found in clusters toward the splenic pe-
riphery (Fig. 1 B). Analysis of bone marrow from E/E and
knockout mice also revealed an expansion of cells in the
myeloid lineage. This similarity between the two mutant
mice was observed histologically (unpublished data) and
by flow cytometry which showed increases in the propor-
tion of CD11b (Mac-1) and Ly-6G (Gr-1/8C5) positive
cells compared with normal littermates (Fig. 1 B, bottom).
The increase in myeloid lineage cells was accompanied by
an equivalent decrease in CD45R(B220) positive cells
(unpublished data).T
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Regulation of ZAP-70 in a c-Cbl(G304E) Mouse
 
The G304E Mutation in c-Cbl Does Not Enhance ZAP-70
Activity in the Thymus.
 
A hallmark of the c-Cbl knockout
mouse is the enhanced and sustained activation of ZAP-70
in thymocytes after antibody cross-linking of CD3 and
CD4 receptors (7, 8). This is evident from the very high
levels of tyrosine phosphorylation of two prominent ZAP-
70 substrates, SLP-76 and LAT (11). Furthermore, ZAP-70
activation in c-Cbl knockout thymocytes is uncoupled
from a requirement for CD4-Lck costimulation. However,
we did not find a similar response when we examined E/E
thymocytes; indeed, the regulation of ZAP-70 activity ap-
peared normal and paralleled that in wild-type thymocytes.
This is illustrated in Fig. 2 A, where the tyrosine phosphor-
ylation pattern clearly shows that ZAP-70 from E/E thy-
mocytes could not be activated by anti-CD3 stimulation
alone, and suceeding the stronger anti–CD3
 
 
 
CD4 costim-
ulatory signal, the phosphorylation of ZAP-70, SLP-76,
and LAT was similar to that of normal littermates. The
marked contrast between the levels of LAT tyrosine phos-
phorylation in c-Cbl(G304E) and c-Cbl
 
 
 
/
 
 
 
 thymocytes
was also shown by LAT immunoprecipitation (Fig. 2 B).
The mutant c-Cbl(G304E) protein is expressed and tyro-
sine-phosphorylated to the equivalent levels of wild-type
c-Cbl (Fig. 2 A). These findings indicate that c-Cbl
(G304E) protein can still negatively regulate the activity of
ZAP-70 in the thymus.
 
Thymocytes were additionally analyzed for effects of
c-Cbl on MAP kinase and PI 3-kinase–signaling pathways.
Consistent with the effect on PTK activation, c-Cbl
knockout thymocytes showed marked activation of Erk1,
Erk2, and Akt as measured by immunoblotting with phos-
phospecific antibodies, whereas E/E thymocytes paralleled
wild-type levels of activation (Fig. 2 C). In addition, un-
stimulated thymocytes from the c-Cbl knockout mouse
showed higher levels of constitutively activated Erk1, Erk2,
and Akt.
To more stringently examine the regulation of ZAP-70
by c-Cbl(G304E), we mated c-Cbl
 
 
 
/
 
 
 
 mice with E/E
mice to discover whether heterozygous offspring with a
single copy of c-Cbl(G304E) could rescue deregulated
ZAP-70. As shown in Fig. 3 A, thymocytes with a single
copy of the mutant allele (E/
 
 
 
) were able to regulate the
tyrosine phosphorylation of ZAP-70, LAT, and SLP-76 as
efficiently as thymocytes expressing two copies of wild-
type c-Cbl. Furthermore, a single copy of c-Cbl(G304E)
was sufficient to revert the thymocytes to their normal re-
quirement for a CD4 costimulatory signal to activate ZAP-
70 (
 
 
 
-CD3 stimulation; Fig. 3 B).
 
Rac Is Constitutively Activated in c-Cbl(G304E) and
c-Cbl
 
 
 
/
 
 
 
 Thymocytes.
 
There is increasing evidence that
Cbl proteins can affect the organization of the actin cyto-
skeleton by regulating Rho family GTPases (for review see
Figure 1. (A) Generation and identification of
c-Cbl(G304E) mice. Genomic organization of the
mouse c-Cbl gene (exons represented by black boxes)
showing the relevant portion targeted for homologous
recombination to introduce the G304E mutation (as-
terisk). Correctly targeted ES cell clones were identi-
fied by PCR using primers p1 and p2 (small dashed
arrows), and confirmed by Southern blotting using
probe A on BamHI-digested genomic DNA. The
loxP-flanked Neo and TK cassettes were removed by
Cre-mediated excision in vivo, leaving only a single
loxP site (solid triangle). Excision was confirmed by
Southern blotting of HindIII-digested genomic DNA
using probe B. Genomic DNA sequenced across the
G304 coding region confirmed the presence of the
G→A nucleotide mutation in the  /E and E/E c-Cbl
allele(s), resulting in the Gly→Glu amino acid change
(bottom left). All mice were subsequently genotyped
by PCR using primers p3 and p4 (small solid arrows) to
detect the wild-type and G304E alleles (bottom right).
B, BamHI; H, HindIII; X, XbaI. Restriction sites indi-
cated in bold are present in the endogenous c-Cbl
gene, whereas those in normal type were introduced
during the construction of the targeting vector. (B)
Top: Spleens from c-Cbl(G304E) and c-Cbl /  mice
have increased numbers of megakaryocytes, megakary-
oblasts, and myelocytes and an expansion in the red
pulp. Spleen sections from 9-wk-old mice were
stained with haematoxylin and eosin. Bar, 100  m.
Bottom: Increase in bone marrow myeloid cells from
c-Cbl(G304E) and c-Cbl knockout mice. Bone mar-
row cells from 8-wk-old mice were analyzed by flow
cytometry for expression of CD11b(Mac-1) and Ly-6G
(Gr-1/8C5) and the percentage of DP cells is indicated
in each window. Equivalent increases in bone marrow
myeloid lineage cells were found in four other experi-
ments examining wild-type and mutant c-Cbl mice.T
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reference 4). The Rho family member Rac regulates cyto-
skeletal organization and TCR clustering, and is required
for T cell maturation and the induction of T cell responses
(for review see reference 17). By assaying the binding of
Rac-GTP to the GST-p21–activated kinase binding do-
main (PAK-1 PBD), we found that unstimulated thy-
mocytes from both c-Cbl(E/E) and c-Cbl /  mice had
markedly higher levels of Rac-GTP compared with wild-
type thymocytes (Fig. 4). The constitutively enhanced
Rac activity from both mutant mice was seen in five ex-
periments and showed on average a three–fourfold in-
crease in the level of Rac-GTP (Fig. 4 B). Interestingly,
Rac-GTP levels were elevated in wild-type and c-Cbl
(E/E) thymocytes after anti-CD3 stimulation, even though
this signal does not activate ZAP-70. The highest levels of
Rac-GTP were seen in c-Cbl knockout thymocytes; this
effect is likely a consequence of ZAP-70 stimulation,
which activates the guanine nucleotide exchange factor
Vav1, leading to increased levels of Rac-GTP (for reviews
see references 17, 18).
Regulation of Lck, ZAP-70, and TCR  Levels in c-Cbl Mu-
tant Mice. A prominent characteristic of c-Cbl knockout
thymocytes is the up-regulation in the level of Lck (11).
When we examined E/E thymocytes by immunoblotting
(Fig. 5 A) and flow cytometry (Fig. 5 B), we found no in-
crease in Lck above that of normal thymocytes. However,
Figure 2. ZAP-70 regulation in activated thymocytes is not affected by
the G304E mutation in the c-Cbl TKB domain. (A) Thymocytes from
c-Cbl / , E/ , E/E, and  /  mice were left unstimulated or stimu-
lated by antibody cross-linking at 37 C for 5 min before lysis. Total cell
lysates were immunoblotted with antiphosphotyrosine and anti–c-Cbl
antibodies. The positions of tyrosine-phosphorylated c-Cbl, SLP-76,
ZAP-70, and LAT are indicated. (B) Thymocytes were treated as afore-
mentioned, but lysates were immunoprecipitated with anti-LAT antibod-
ies and immunoblotted with either antiphosphotyrosine or anti-LAT an-
tibodies. (C) MAPK and Akt activation is not enhanced in c-Cbl(G304E)
thymocytes. Thymocytes from c-Cbl / , E/ , E/E, and  /  mice
were treated as in A. Total cell lysates were immunoblotted with phos-
pho-p44/42 anti–Erk 1/2 and phospho-Akt antibodies. The levels of
each protein were determined by immunoblotting with anti–Erk 1/2 and
anti-Akt antibodies.
Figure 3. The enhanced activity of ZAP-70 in c-Cbl /  thymocytes
is suppressed by a single copy of c-Cbl(G304E). Thymocytes from
c-Cbl / , E/E, E/ , and  /  mice were left unstimulated or stimu-
lated by antibody cross-linking for 5 min at 37 C before lysis. (A) Total
cell lysates immunoblotted with antiphosphotyrosine antibodies. The po-
sitions of tyrosine-phosphorylated c-Cbl, SLP-76, ZAP-70, and LAT are
indicated. (B) Lysates were also immunoprecipitated with anti–ZAP-70
antibodies followed by immunoblotting with antiphosphotyrosine and
anti–ZAP-70.
Figure 4. Rac is constitutively activated in thymocytes from c-Cbl
(G304E) and knockout mice. (A) Lysates from unstimulated thymocytes
or thymocytes stimulated by antibody cross-linking for 30 s at 37 C were
incubated with agarose-bound GST-PAK-1 PBD. The levels of Rac-
GTP bound to the Sepharose beads; in total, lysates were analyzed by im-
munoblotting with an anti-Rac antibody. (B) Densitometric scans for
anti-Rac blots of GST-PAK-PBD–bound proteins from unstimulated
thymocytes were obtained from five experiments and the averages plotted.
Error bars represent standard deviations.T
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a consistent feature in c-Cbl /  and E/E thymii was a re-
duction in Lck protein levels after stimulation (Fig. 5 A).
Whether this is a consequence of lowered antibody detec-
tion due to protein modification and/or enhanced degrada-
tion is unknown.
The ability to measure intracellular Lck by flow cytome-
try allowed us to compare levels in immature thymocytes,
which express low levels of CD3 (i.e., CD3lo), with mature
thymocytes (CD3hi). Analysis of these populations showed
that the up-regulation of Lck in the knockout mouse is re-
stricted to immature thymocytes (Fig. 5 C), with no ob-
servable difference compared with wild-type levels on mat-
uration (Fig. 5 D). Interestingly, two color analysis of
surface CD3 and intracellular c-Cbl in wild-type thy-
mocytes showed no difference in c-Cbl expression be-
tween CD3lo and CD3hi thymocytes (unpublished data).
This suggests that the wild-type levels of Lck in the mature
c-Cbl /  thymocytes is not a result of their normal coun-
terparts being unable to express high levels of c-Cbl pro-
tein. At present, we do not understand why c-Cbl does not
appear to affect Lck levels in mature thymocytes.
We showed previously that ZAP-70 levels were unal-
tered in knockout thymocytes (11) and, as expected,
ZAP-70 levels were also normal in E/E thymocytes (Fig.
5 A). Intracellular staining and flow cytometry also re-
vealed that ZAP-70 levels were not altered in thymocytes
or peripheral T cells of either c-Cbl mutant mouse (un-
published data).
TCR  levels in c-Cbl /  thymocytes are also en-
hanced (11), which is consistent with a recent report show-
ing that c-Cbl promotes TCR  ubiquitylation (19). To ex-
amine whether the TKB domain mutation can affect
TCR  levels, we compared thymocytes and T cells from
c-Cbl wild-type, E/E, and knockout mice (Fig. 5 E). Two
color flow cytometry of CD3  (extracellular) and TCR 
(intracellular) revealed that immature thymocytes (CD3lo)
from E/E mice express normal levels of TCR . As with
Lck, the up-regulation of TCR  in the knockout mouse
was restricted to immature thymocytes (CD3lo) because
wild-type levels were found in both CD3hi thymocytes and
peripheral T cells (Fig. 5 E).
Down-regulation of CD3 on Mature Thymocytes and Periph-
eral T Cells from -Cbl /  and G304E Mutant Mice. The
proportion of cells in the major thymic subsets as defined
by CD4 and CD8 are normal in the c-Cbl /  mouse (7,
8), and here we find the E/E thymus to be similarly unal-
tered (unpublished data). However, CD4 CD8  DP thy-
mocytes from the c-Cbl /  mouse have markedly en-
hanced levels of CD3 and TCR (7, 8). In contrast, DP
thymocytes from the E/E mouse showed no evidence of
this enhancement because receptor levels were nearly
equal, though not identical, to that of normal littermates
Figure 5. (A) Regulation of Lck and ZAP-70 levels
in thymocytes from c-Cbl mutant mice. Thymocytes
from c-Cbl / , E/E, and  /  mice were left un-
stimulated or stimulated by antibody cross-linking for 5
min at 37 C and levels of c-Cbl, ZAP-70, and Lck de-
termined by immunoblotting of total lysates. (B–D)
Thymocytes were stained with anti–CD3-PE antibod-
ies before fixing and intracellular staining with either
anti-Lck monoclonal antibody or a mouse IgG isotype
control. Antibody binding was detected with an APC-
conjugated goat anti–mouse Ig, and the cells were ana-
lyzed by flow cytometry. (B) Lck staining of wild-type
thymocytes (shaded histogram) and E/E thymocytes
(bold line) showed identical overlapping profiles,
whereas Lck levels in c-Cbl /  thymocytes are ele-
vated (long dashes). The isotype antibody control for
wild-type thymocytes is shown by small dashes. (C and
D) Wild-type and c-Cbl /  thymocytes were gated
for CD3-lo and CD3-hi populations, respectively, and
intracellular staining for Lck is shown for wild type
(shaded histograms) and c-Cbl /  (long dashes). The
isotype antibody control for wild-type thymocytes is
shown by small dashes. (E) TCR  levels in c-Cbl mu-
tant mice. Thymocytes and lymph node cells were
stained with PE-conjugated anti-CD3 antibodies be-
fore fixing and intracellular staining for TCR . After
flow cytometric analysis, thymocytes were gated into
CD3-lo and CD3-hi populations, and lymph nodes
cells were gated for CD3  cells. Intracellular levels of
TCR  are shown from wild-type (shaded histograms),
c-Cbl E/E (bold line), and c-Cbl /  (long dashes)
mice. The isotype antibody control for wild-type thy-
mocytes is shown by small dashes and was identical to
the isotype controls from mutant mice.T
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(Fig. 6, B and F, compare shaded histogram of wild type
with bold line of E/E). We consistently found a minimal
reduction in CD3 (Fig. 6 B) and a slight enhancement in
TCR levels in E/E DP thymocytes (Fig. 6 F), but neither
change was comparable in magnitude to the effect seen in
the knockout.
A surprising but consistent feature of the anti-CD3 pro-
files was the reduced surface expression on mature thy-
mocytes (i.e., CD3hi) from both c-Cbl /  and E/E mice
(Fig. 6 A, bright cells). This was readily apparent when we
examined single positive (SP) CD4  and CD8  thy-
mocytes and found both mutant strains to have equivalent
reductions in CD3 levels compared with normal littermates
(Fig. 6, C and D). This identity was seen for all E/E and
 /  mice, even when we compared CD3 levels between
different litters and different experiments. Thus, a strong
selection pressure exists in c-Cbl mutant mice to express
reduced levels of CD3 on mature thymocytes. This also in-
dicates that the selection is precisely regulated and likely to
involve a signaling perturbation that is common to both
mutant strains.
A similar reduction in CD3 expression was also observed
in peripheral T cells from spleens (unpublished data) and
lymph nodes (Fig. 6 G) of c-Cbl /  and E/E mice, and
seen in both CD4  and CD8  subsets (Fig. 6, H and I).
The identical down-regulation of CD3 in both mutant
mice was also evident with the 17A2 and 500A2 mono-
clonal antibodies (unpublished data), which recognize
epitopes on CD3  distinct to those recognized by the 145-
2C11 antibody used in all CD3 experiments in this paper
(20). Lymph node T cells from heterozygous  /E mice
showed levels of CD3 intermediate to  /  and E/E T
cells (Fig. 6 J). Thus, the  /E mouse has a mild CD3 phe-
notype that correlates with gene dosage. This finding fur-
ther indicates that c-Cbl can tightly regulate the level of
CD3 that is ultimately expressed on selected mature T cells.
In contrast to CD3, no difference in TCR levels was
seen on mature thymocytes (Fig. 6 E, TCRhi cells) and
lymph node T cells (Fig. 6, K and L) between normal lit-
termates and mutant c-Cbl mice. This differential regula-
tion of CD3 and TCR may be a consequence of the differ-
ent roles played by these two classes of receptor; TCR is
involved in antigen recognition but does not contribute to
intracellular signaling, whereas CD3 components each
contain an immune receptor tyrosine-based activation mo-
tif that is required to initiate downstream signaling events.
Furthermore, in contrast to the TCR heterodimer, the
CD3  subunit contains endocytosis signals (21), although
these signals are thought to contribute to the internalization
and cell-surface down-regulation of the entire TCR–CD3
complex (9), rather than individual components as these
data suggest.
To examine the regulation of CD3 in more detail, we
compared mutant and wild-type mice for intracellular lev-
els by incubating lymph node cells with unlabeled anti-
CD3 antibodies to block cell-surface receptors followed
by fixing, permeabilizing, and staining with anti–CD3-
PE. Preincubation with unlabeled antibodies completely
blocked surface staining with either PE or APC-labeled
anti-CD3 antibodies (unpublished data). We found that the
reduction of surface CD3 on lymph node T cells from
c-Cbl /  and E/E mice (Fig. 7 A) was not paralleled in-
tracellularly because all three mice showed equivalent levels
of intracellular CD3 (Fig. 7 B). Thus, altered regulation by
mutant c-Cbl specifically affects the amount of CD3 at the
cell surface, not the intracellular pool. In contrast, both sur-
face and intracellular levels of TCR  are unaltered be-
tween wild-type and mutant T cells (Fig. 7, C and D).
Up-regulation of CD5 and CD69 in c-Cbl /  and G304E
DP Thymocytes. CD5 is a cell-surface glycoprotein ex-
pressed on thymocytes, mature T cells, and a subset of B
Figure 6. c-Cbl /  and G304E mutant mice show down-regulation
of CD3  on mature thymocytes and peripheral T cells. Ungated (Total
thymocytes) or gated DP, CD4 SP, and CD8 SP thymocytes from wild-
type (shaded histogram), c-Cbl(E/E) (bold line), and c-Cbl /  (dashed
line) mice were analyzed by flow cytometry for cell-surface expression of
CD3  (A–D) and TCR  (E and F). (G–I) Lymph node cells were ana-
lyzed for cell-surface expression of CD3 , which is shown on ungated
lymph node cells, CD4 SP, or CD8 SP T cells from wild-type (shaded
histogram), c-Cbl(E/E) (bold line), and c-Cbl /  (dashed line) mice,
respectively. TCR  expression for this experiment is shown on ungated
lymph node cells in K. (J and L) Lymph node cells from wild-type
(shaded histogram), c-Cbl(E/E) (bold line), and heterozygous c-Cbl( /E)
(normal line) mice were analyzed for cell-surface expression of CD3  and
TCR , respectively.T
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cells that negatively regulates signaling through antigen re-
ceptors (22). CD5 expression on DP thymocytes has been
found to parallel the affinity of the positively selecting
TCR-MHC–ligand interaction, suggesting that its expres-
sion fine tunes the strength of the TCR–CD3 signaling re-
sponse that selects the mature TCR repertoire (23). These
observations are consistent with the up-regulation of CD5
seen in c-Cbl knockout DP thymocytes where the TCR–
CD3 response is markedly enhanced (8). The G304E
knock-in mouse also shows up-regulated CD5 expression
on DP thymocytes, but the increase is less pronounced
compared with knockout thymocytes (Fig. 8 A). Further-
more, when we compared DP thymocytes from c-Cbl
 /E, E/E, E/ , and  /  mutant mice, we found se-
quential increases in CD5 that paralleled the severity of the
mutation (Fig. 8 B). This effect indicates that perturbations
in signal strength caused by mutant forms of c-Cbl are
linked to, and finely tuned by, CD5 in a gene dosage-
dependent manner. Up-regulation of CD5 in E/E DP thy-
mocytes is additional evidence of enhanced signaling in this
population, but this does not appear to involve deregula-
tion of ZAP-70 activity.
CD69 is another marker whose expression is an indicator
of thymocyte activation. It is induced on DP thymocytes
within 24 h of productive TCR engagement by thymic
ligands (24), and its up-regulation occurs during both posi-
tive and negative selection (25–27). As reported previously
(8), DP thymocytes from the c-Cbl knockout mouse ex-
press higher levels of CD69 than those from wild-type
mice (Fig. 8 C). As with CD5 expression, we found DP
thymocytes from the E/E mouse also expressed elevated
levels of CD69, but again the effect was not as marked as
that seen for the knockout mouse. Analysis of mature thy-
mocytes and lymph node T cells for levels of CD5 and
CD69 revealed no differences between mutant and wild-
type mice (unpublished data), further illustrating that c-Cbl
effects on signaling appear to be limited to the DP popula-
tion, whereas normal regulatory controls are restored in
mature T cells.
Discussion
An unexpected outcome of our analysis of the c-Cbl
(G304E) mouse is the finding that the c-Cbl TKB domain
does not appear to be necessary for the negative regulation
of ZAP-70 in vivo. This conclusion is drawn from the
markedly different effects on ZAP-70 activation in thy-
mocytes from the c-Cbl knockout compared with the c-Cbl
(G304E) knockin mouse. At face value this finding
contradicts a very large body of evidence showing that the
Figure 7. c-Cbl /  and G304E mutant mice show reduced surface,
but not intracellular, CD3  levels in lymph node T cells. Lymph node
cells were incubated with anti–CD3 -PE (A) or anti–TCR -FITC (C)
antibodies to determine cell-surface expression levels. To determine in-
tracellular levels of CD3, the cells were first incubated with unlabeled
anti-CD3  antibodies to block surface CD3 receptors, and then fixed,
permeabilized, and stained with anti–CD3 -PE (B). Intracellular TCR 
was determined by first blocking with FITC–labeled anti-TCR , followed
by fixing, permeabilizing, and staining with anti–TCR -PE (D). Flow
cytometry profiles show lymph node cells from 6-wk-old wild-type
(shaded histogram), c-Cbl(E/E) (bold line), and c-Cbl /  (dashed line)
mice. Pretreating the viable cells with unlabeled anti-CD3 or FITC-
labeled anti-TCR was found to completely block these receptors from
further surface staining (unpublished data).
Figure 8. Up-regulation of
CD5 and CD69 on thymocytes
from c-Cbl /  and G304E
mice. (A) DP thymocytes from
8-wk-old wild-type (shaded his-
togram), c-Cbl(E/E) (bold line),
and c-Cbl /  (dashed line)
mice were analyzed for cell-sur-
face expression of CD5. (B) The
same flow cytometry profiles as
in A, except additional profiles
from heterozygous  /E thy-
mocytes (dotted line) and E/ 
thymocytes (normal continuous line) are included. (C) DP thymocytes from wild-type (shaded histogram), c-Cbl(E/E) (bold line), and c-Cbl / 
(dashed line) mice were analyzed for cell-surface expression of CD69.T
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c-Cbl TKB domain is essential for c-Cbl to negatively
regulate ZAP-70. This was first implied by the demonstra-
tion of a direct interaction between the TKB domain and
phosphorylated tyrosine 292 in ZAP-70 (28), previously
identified as a negative regulatory site in ZAP-70 (29, 30).
The interaction between ZAP-70 and the c-Cbl TKB do-
main has since been extensively characterized by an array
of experimental systems and two structural studies (for re-
views see references 4, 31). These all provide compelling
evidence that c-Cbl functions as a negative regulator of
ZAP-70 by TKB-domain targeting of phosphorylated ty-
rosine 292. However, such studies have principally been
performed by transient transfection of Jurkat T cells, and
none of these have clearly defined how the TKB domain
is affecting the activity of ZAP-70. Furthermore, most
studies have relied on NF-AT reporter gene expression as
the means of measuring ZAP-70 function, so the direct
effects of c-Cbl on upstream signaling proteins requires
further investigation.
Consistent with there being no apparent effect of TKB
domain mutation on ZAP-70 activity, we also found no
phenotypic similarities to the ZAP-70(Y292F) mouse (32).
The ZAP-70(Y292F) mouse does show a minimal overlap-
ping phenotype with the c-Cbl knockout mouse in terms
of increased LAT and TCR  tyrosine phosphorylation, but
neither of these characteristics are seen in the G304E
mouse. Furthermore, unlike the c-Cbl(G304E) mouse, DP
and SP thymocytes from the ZAP-70(Y292F) mouse ex-
press normal levels of CD5 and CD3 , respectively. These
findings indicate that even if the phenotypic effects seen in
the c-Cbl(G304E) mouse are due to a presently unknown
aspect of ZAP-70 function, they are clearly not mediated
through phospho-Y292. In addition, the c-Cbl and ZAP-
70 mutant mice do not show altered ZAP-70 protein lev-
els, which indicates that c-Cbl, or another E3 ligase, does
not target phospho-Y292 and direct ZAP-70 polyubiquity-
lation and degradation. Our comparison of c-Cbl knockout
and G304E knockin mice has also clearly shown that it
must be regions other than the TKB domain that are re-
sponsible for the negative regulation of ZAP-70, as well as
controlling levels of TCR, CD3, and Lck in DP thy-
mocytes. Therefore, it will be of interest to generate mice
with mutations that affect regions outside the TKB do-
main, such as the RING finger and sequences involved in
SH2 and SH3 domain interactions.
In this paper, the absence of an effect on ZAP-70 signal-
ing by the G304E mutation was determined by examining
the tyrosine phosphorylation of ZAP-70 and its substrates
as well as the downstream activation of Erk and Akt. These
findings suggested that signaling in G304E thymocytes is
unaltered, and therefore should reveal phenotypic charac-
teristics equivalent to that of wild-type mice. Surprisingly,
we found some parameters were altered, and indeed paral-
leled the knockout mouse. One of these was the reduced
level of CD3  on mature SP thymocytes and peripheral T
cells. An identical decrease in cell-surface expression of
CD3  was seen in both mutant strains, suggesting that the
same signaling events are perturbed. Furthermore, we
found that the decrease in surface CD3  was not due to a
global reduction in CD3  levels because an equivalent de-
crease was not found by staining for the intracellular pool
of CD3 . Surprisingly, surface TCR  levels are unaffected
by this reduction in surface CD3 . This was an unexpected
finding because only fully formed TCR–CD3 hexameric
complexes are thought to exit the endoplasmic reticulum
and therefore TCR subunits should only be expressed on
the cell surface as part of a complete complex (33). Fur-
thermore, it has recently been shown that CD3  , CD3  ,
and CD3   homodimers, as well as CD3   heterodimers,
cannot exist (34), therefore it is unlikely that excess TCR
on the surface is complexed with aberrant combinations of
CD3 subunits. However, our data from c-Cbl mutant T
cells does suggest that TCR   chains are expressed on the
cell surface in the absence of normal levels of CD3  sub-
units, and because no precedent exists for this phenotype,
the mechanism requires further investigation.
From a functional perspective, we predict that reduced
surface expression of CD3 is occurring to compensate for
enhanced signaling in thymocytes undergoing selection,
and the key task that emerges from this is to identify the
nature of these signaling events. In the c-Cbl knockout
mouse, the DP thymocytes exhibit numerous perturbations
in the selecting population, i.e., increased levels of TCR ,
TCR , CD3 , and Lck, in addition to the altered regula-
tion of ZAP-70, and these are prime candidates to explain
the enhanced signaling observed after thymocyte stimula-
tion (11). In spite of these perturbations, functionally nor-
mal T cells emerge in the periphery (7, 8). This is presum-
ably because the knockout thymus has developed efficient
mechanisms of compensation, and the selection of mature
thymocytes with reduced surface CD3 levels is a likely
component. In contrast, DP thymocytes from the c-Cbl
(G304E) mouse show no increases in the levels of TCR ,
TCR , CD3 , and Lck, nor is there enhanced activity of
ZAP-70, Erk, or Akt, although CD3  is down-regulated
on selected thymocytes and T cells. From this, we con-
clude that the down-regulation of CD3  on selected T
cells from the knockout mouse may in fact be a conse-
quence of enhanced signaling that involves pathways unre-
lated to those associated with deregulated receptor levels
and ZAP-70 activity described previously.
A characteristic that supports enhanced signaling in DP
thymocytes from the G304E mouse is the increased expres-
sion of CD5 and CD69, both of which are indicators of
thymocyte activation. The increase is not as marked as that
seen in the knockout mouse, presumably because of addi-
tional contributions mediated by the up-regulation of
TCR, CD3, Lck, and ZAP-70 in the knockout. However,
identifying the signaling events in the G304E knockin
mouse responsible for enhanced CD5 and CD69 expres-
sion, which necessitate the down-regulation of CD3 levels,
is an important task.
We have identified the signaling candidate Rac, a mem-
ber of the Rho family of GTPases that regulates actin reor-
ganization in response to stimulatory signals and is required
for the formation of the immunological synapse. Impor-T
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tantly, we found increased Rac-GTP levels in unstimu-
lated thymocytes from both c-Cbl knockout and knockin
mice. It may be that weak signals in the thymic environ-
ment are sufficiently enhanced at the level of Rac to pro-
mote excess actin-driven TCR–CD3 clustering, which
sustains the signaling necessary for thymocyte activation.
Indeed, the movement of the TCR–CD3 complex at the
peak of ligand-induced signaling correlates with its linkage
to actin (2), and a shift in the strength of this signal may be
sufficient to alter the phenotype of selected thymocytes
and T cells. Furthermore, it is significant that the CD3 
subunit has recently been shown to be directly involved in
this process via an activation-induced association with
Nck, which functions as a scaffold to link signaling effec-
tors involved in actin reorganization (35). Thus, CD3  is
an essential signaling component in the formation of the
immunological synapse, and its altered expression is pre-
dicted to affect downstream proteins such as Rac. Further-
more, an effect on cytoskeletal regulation in c-Cbl mutant
mice would be consistent with effects seen in peripheral T
cells from Cbl-b knockout mice. These mice revealed that
Cbl-b functions as a negative regulator of TCR clustering
by enhancing the activity of Vav1 and the Rho family
member Cdc42 (36). However, these effects are restricted
to peripheral T cells and are not evident in the thymus (37,
38). Indeed, analyses of Cbl-b knockout mice indicate that
Cbl-b does not play a role in thymocyte signaling (37, 38),
possibly because its levels are at least fivefold lower than
those of c-Cbl (unpublished data). However, perturbations
at the thymocyte level may be less detrimental for c-Cbl
mutant mice as they have the opportunity to make the
necessary adjustments to produce functionally normal T
cells, thus avoiding autoimmune disease that develops in
Cbl-b–deficient mice (37, 38).
The analysis of a mouse with a mutation that was origi-
nally described in C. elegans also raises the question of how
these findings help to explain the rescue of a reduction-of-
function mutation in the LET-23 receptor tyrosine kinase.
At this point, the results may be helpful in directing analy-
ses toward the possibility that the rescue may involve en-
hanced signaling at the level of a Rho family member,
rather than a direct effect on LET-23 or other PTKs. The
lack of evidence of enhanced ZAP-70 signaling in
Cbl(G304E) thymocytes indicates that this is a possibility
worthy of consideration.
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